Monetta Financial Services Inc. purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 20,000 shares of the company's stock, valued at approximately $1,159,000.
Several other large investors have also bought and sold shares of TEM. Victory Capital Management Inc. raised its position in shares of Tempus AI by 1.5% during the third quarter. Victory Capital Management Inc. now owns 11,078 shares of the company's stock worth $894,000 after acquiring an additional 162 shares during the last quarter. Truist Financial Corp boosted its position in shares of Tempus AI by 5.8% during the 4th quarter. Truist Financial Corp now owns 3,532 shares of the company's stock worth $209,000 after purchasing an additional 194 shares in the last quarter. Farther Finance Advisors LLC grew its stake in Tempus AI by 3.5% in the fourth quarter. Farther Finance Advisors LLC now owns 6,390 shares of the company's stock valued at $377,000 after acquiring an additional 219 shares during the period. SeaCrest Wealth Management LLC grew its position in Tempus AI by 3.7% in the 3rd quarter. SeaCrest Wealth Management LLC now owns 6,488 shares of the company's stock valued at $524,000 after purchasing an additional 229 shares during the period. Finally, Geneos Wealth Management Inc. increased its position in shares of Tempus AI by 29.4% during the fourth quarter. Geneos Wealth Management Inc. now owns 1,100 shares of the company's stock worth $65,000 after acquiring an additional 250 shares in the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of analysts recently commented on TEM shares. Wall Street Zen raised Tempus AI from a "sell" rating to a "hold" rating in a research report on Saturday, July 25th. Lake Street Capital cut shares of Tempus AI to a "hold" rating in a research note on Monday, July 20th. BTIG Research reduced their target price on Tempus AI from $80.00 to $70.00 and set a "buy" rating for the company in a report on Monday, August 3rd. TD Cowen reaffirmed a "buy" rating on shares of Tempus AI in a report on Wednesday, July 15th. Finally, HC Wainwright lowered their target price on shares of Tempus AI from $64.00 to $56.00 and set a "buy" rating on the stock in a research note on Monday, August 3rd. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Tempus AI has an average rating of "Hold" and a consensus target price of $64.92.
Get Our Latest Stock Analysis on TEM
Insiders Place Their Bets
In other Tempus AI news, CFO James William Rogers sold 11,529 shares of the stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $55.00, for a total transaction of $634,095.00. Following the transaction, the chief financial officer directly owned 114,866 shares in the company, valued at $6,317,630. This represents a 9.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Eric P. Lefkofsky sold 250,000 shares of Tempus AI stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $42.06, for a total value of $10,515,000.00. Following the completion of the transaction, the chief executive officer owned 200,000 shares in the company, valued at $8,412,000. This represents a 55.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 684,424 shares of company stock worth $33,255,565 over the last three months. 24.26% of the stock is currently owned by corporate insiders.
Tempus AI Trading Up 24.1%
Shares of NASDAQ:TEM opened at $61.25 on Thursday. The company has a market cap of $11.05 billion, a PE ratio of -42.53 and a beta of 3.58. Tempus AI, Inc. has a 12-month low of $40.77 and a 12-month high of $104.32. The stock has a 50 day moving average of $52.10 and a 200 day moving average of $51.16. The company has a current ratio of 3.30, a quick ratio of 3.16 and a debt-to-equity ratio of 3.06.
Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.10. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The company had revenue of $382.49 million for the quarter, compared to the consensus estimate of $379.69 million. During the same period in the previous year, the firm posted ($0.22) EPS. Tempus AI's revenue for the quarter was up 21.6% compared to the same quarter last year. As a group, equities research analysts expect that Tempus AI, Inc. will post -1.38 EPS for the current year.
Tempus AI Profile
(
Free Report)
Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.
The company's core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
